Whole Genome Sequencing
The advance of whole genome sequencing technology accelerates the identification of key genetic trait or alteration leading to disease development. The major function of current massively parallel genome sequencers is to perform de novo assembly or resequencing of euchromatic regions, about 94% of entire human genome and representing the reference genome firstly obtained after completion of Human Genome Project. Massively parallel short or medium reads of tens to few thousands with sufficient coverage are able to piece together contiguous euchromatic sequences tolerating 1-4% error rate primarily from inherited DNA polymerase infidelity. However, these short- or medium-read sequencers are not suitable for determining heterochromatic sequences, which cover the yet-to-be completed 6% human genome and contain long repetitive nuclear elements, including the 45S rDNA , about 45-kb per copy and estimated 400 copies distributed across short arms of five human acrocentric chromosomes, and satellite DNAs in centromere. The tandemly repeated 45S rDNA and satellite DNAs are recombinational hot spots and are sealed throughout eukaryotes. Recent evidence further suggests that 45S rDNA rearrangement and concurrent epigenetic changes play a role in mammalian ontogeny and tissue differentiation, and are associated with speciation, aging, cancers, psychological disorders, and neurodegenerative diseases.
The need to develop sequencing platforms capable of reading continuously a single long-stretch DNA/RNA strand with high accuracy is urgent. Several newly proposed approaches show a potential to achieve long-reads of 50 kb or more, and are at various stages of development toward commercialization. These include new version of single molecule real time (SMRT) technology, biological and solid-state nanopore, nanogap, nanoribbon, nanochannel, and electron microscopy, which are moving away from fluorescence-based detection to electronic sensing or imaging.
- Whole genome sequencing
- Next Generation Sequencing
- Third generation sequencing
- De novo sequencing
- Targeted gene sequencing
- Trends in DNA and RNA sequencing techniques
Related Conference of Whole Genome Sequencing
19th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genomics and Genomic Medicine
1st EMBL Conference Cancer Genomics Heidelberg Germany
Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America
New Fronteirs in Gene Editing San Francisco United States of America
HPLC Congress 2016 London United Kingdom
2016 Genetics and Genomics Conference Vienna Austria
Genome Editing and Engineering Conference San Diego United States of America
Keystone Symposia Stem Cells and Cancer Breckenridge United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
Human Genomics Singapore Singapore
The Probiotics Congress Asia Kuala Lumpur Malaysia
Whole Genome Sequencing Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- 3D Bio-Printing and Organ Printing - Stemgen 2024 (UK)
- 3D bioprinting using Stem Cells - Stemgen 2024 (UK)
- Advanced Gene Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Advances in Cell Therapy Research - REGENERATIVE MED MEET 2024 (UK)
- Applications of Stem Cells - Stemgen 2024 (UK)
- Applications of Tissue engineering & Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Bio Banking - Stemgen 2024 (UK)
- Bio Banking Stem cell - Stem Cell 2024 (Ireland)
- Bioengineering Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (France)
- Biologic Scaffolds for Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Biomaterials & Bioengineering - REGENERATIVE MED MEET 2024 (UK)
- Bone Marrow Transplantation - Stem Cell 2024 (Ireland)
- Bone Marrow Transplantation - Stemgen 2024 (UK)
- Cancer Stem Cell and Oncology - Stemgen 2024 (UK)
- Cancer Therapies - WORLD CELL THERAPY 2024 (UK)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (France)
- Cell and Gene Therapy - Stemgen 2024 (UK)
- Cell Culture and Bio processing - WORLD CELL THERAPY 2024 (UK)
- Cell Science and Stem Cell Research - WORLD CELL THERAPY 2024 (UK)
- Cell Therapy and Regenerative Medicine Market - REGENERATIVE MED MEET 2024 (UK)
- Cell Therapy in Pulmonology - WORLD CELL THERAPY 2024 (UK)
- Cellular Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (France)
- Clinical Methods - Stem Cell 2024 (Ireland)
- Clinical Trials and Research in Cell and Gene Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Trials on Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Dental Stem Cell - Stemgen 2024 (UK)
- Dental Stem Cells - Stem Cell 2024 (Ireland)
- Diabetes Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Effect of Aging on Stem Cells - Stemgen 2024 (UK)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (France)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (France)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (France)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (France)
- Gene Therapy - REGENERATIVE MED MEET 2024 (UK)
- Genetic Vaccines - WORLD CELL THERAPY 2024 (UK)
- HIV Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Genetics - HUMAN GENETICS MEET 2024 (France)
- Immunotherapy - REGENERATIVE MED MEET 2024 (UK)
- Immunotherapy - WORLD CELL THERAPY 2024 (UK)
- Models of Regeneration - REGENERATIVE MED MEET 2024 (UK)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (France)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (France)
- Molecular Epigenetics - WORLD CELL THERAPY 2024 (UK)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (France)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (France)
- Nano-Therapy - WORLD CELL THERAPY 2024 (UK)
- Nanotechnology in Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Nanotechnology in Stem Cell - WORLD CELL THERAPY 2024 (UK)
- Neurodegenerative Disease - Stem Cell 2024 (Ireland)
- New Market Trends, R&D on Stem Cells - Stemgen 2024 (UK)
- Novel Approaches guided in Tissue Engineering - REGENERATIVE MED MEET 2024 (UK)
- Novel Stem Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Orthopedics, Sports Medicine and Regenerative Rehabilitation - REGENERATIVE MED MEET 2024 (UK)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (France)
- Regeneration and Therapeutics - Stem Cell 2024 (Ireland)
- Regenerative Medicine - Stemgen 2024 (UK)
- Regenerative Medicine in Aging, Dermatology and Plastic Surgery - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine Research - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine research and development - Stemgen 2024 (UK)
- Regenerative Therapy in Osteoarthritis - Stemgen 2024 (UK)
- Research and Development of Stem Cell & Regenerative Drugs - Stem Cell 2024 (Ireland)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (France)
- Skin Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Stem Cell and Tissue Engineering - Stemgen 2024 (UK)
- Stem Cell Animal Applications - Stem Cell 2024 (Ireland)
- Stem Cell Apoptosis and Signal Transmission - Stem Cell 2024 (Ireland)
- Stem Cell Embryology - Stem Cell 2024 (Ireland)
- Stem cell engineering - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Cardiovascular Disease - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Development - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Discovery - Stem Cell 2024 (Ireland)
- Stem Cell Therapies - WORLD CELL THERAPY 2024 (UK)
- Stem Cell Therapy - Stemgen 2024 (UK)
- Stem Cell Transplantation - Stem Cell 2024 (Ireland)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (France)
- Stem Cell Transplantation to Avoid Cancer - Stemgen 2024 (UK)
- Stem Cells - Stem Cell 2024 (Ireland)
- Stem Cells and Disease Modelling - Stemgen 2024 (UK)
- The use of Stem Cells for COVID-19 Therapy - Stemgen 2024 (UK)
- Theories of Aging in Stem Biology - Stem Cell 2024 (Ireland)
- Tissue Engineering - Stem Cell 2024 (Ireland)
- Tissue Science and Engineering - REGENERATIVE MED MEET 2024 (UK)
- Translational Medicine - HUMAN GENETICS MEET 2024 (France)
- Translational Research in Stem Cell Assessments - Stem Cell 2024 (Ireland)
- Viral gene therapy - WORLD CELL THERAPY 2024 (UK)